Vinorelbine(CAS: 71486-22-1)

CAS号
相关产品
2-[6-[6-[6-[6-[4,5-Dihydroxy-2-(hydroxymethyl)-6-[4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
CAS号: 34620-78-5
其他供应商提供的 Vinorelbine
基本信息
分子式
C45H54N4O8
分子量
778.95 g/mol
物理状态
Powder
化学标识符
SMILES
CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC
InChIKey
GBABOYUKABKIAF-BXZSYHTRSA-N
数据库引用
MDL号
MFCD00866248
常见问题
长春瑞滨是一种抗肿瘤药物,属于植物类生物碱,主要用于治疗非小细胞肺癌和乳腺癌等恶性肿瘤。
长春瑞滨主要用于治疗非小细胞肺癌、乳腺癌等恶性肿瘤。它通过干扰肿瘤细胞的DNA合成,导致肿瘤细胞死亡。
使用长春瑞滨存在一定风险,可能会引起一系列副作用,如恶心、呕吐、脱发、骨髓抑制等。使用时应遵循医生指导,定期监测血液指标,注意个人防护,避免接触眼睛和皮肤。
长春瑞滨应储存在阴凉、干燥处,避免高温和光照,温度应控制在2-8℃。应使用专用容器密封保存,并确保容器无破损。
安全须知
使用前请验证产品规格和安全数据。联系供应商获取详细安全信息。
请始终遵循正确的操作程序


![4-{(1R,3aS,4R,6aS)-4-[4-(beta-D-Glucopyranosyloxy)-3,5-dimethoxyphenyl]tetrahydro-1H,3H-furo[3,4-c]furan-1-yl}-2,6-dimethoxyphenyl beta-D-glucopyranoside](https://cnstatic.chemtradehub.com/structs/667/66791-77-3-74b7.webp)


![2-[6-[6-[6-[6-[4,5-Dihydroxy-2-(hydroxymethyl)-6-[4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol](https://cnstatic.chemtradehub.com/structs/346/34620-78-5-d616.webp)

![2-(3,4-Dihydroxy-5-methoxyphenyl)-5-(beta-D-glucopyranosyloxy)-7-hydroxy-3-chromeniumyl 6-O-{6-deoxy-4-O-[(2E)-3-(4-hydroxyphenyl)-2-propenoyl]-alpha-L-mannopyranosyl}-beta-D-glucopyranoside chloride](https://cnstatic.chemtradehub.com/structs/699/69915-09-9-afab.webp)



